Barclays’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Sell |
29,377
-29,353
| -50% | -$37K | ﹤0.01% | 3994 |
|
|
2025
Q1 | $72K | Buy |
58,730
+8,926
| +18% | +$10.9K | ﹤0.01% | 3792 |
|
|
2024
Q4 | $89K | Buy |
49,804
+10,945
| +28% | +$19.6K | ﹤0.01% | 3825 |
|
|
2024
Q3 | $198K | Buy |
38,859
+36,316
| +1,428% | +$185K | ﹤0.01% | 3486 |
|
|
2024
Q2 | $18K | Buy |
+2,543
| New | +$18K | ﹤0.01% | 3914 |
|
|
2022
Q2 | – | Sell |
-2,850
| Closed | -$24K | – | 4960 |
|
|
2022
Q1 | $24K | Buy |
+2,850
| New | +$24K | ﹤0.01% | 4282 |
|